Journal Articles
Molecular Therapy - Methods and Clinical Development
Year : 2018
guillaume corre : Connect in order to contact the contributor
https://hal-univ-evry.archives-ouvertes.fr/hal-02178306
Submitted on : Tuesday, July 9, 2019-4:41:08 PM
Last modification on : Monday, November 28, 2022-5:32:06 PM
Dates and versions
Identifiers
- HAL Id : hal-02178306 , version 1
- DOI : 10.1016/j.omtm.2018.10.014
- PUBMEDCENTRAL : PMC6276308
Cite
Valentina Poletti, Fabrizia Urbinati, Sabine Charrier, Guillaume Corre, Roger Hollis, et al.. Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy - Methods and Clinical Development, 2018, 11, pp.167-179. ⟨10.1016/j.omtm.2018.10.014⟩. ⟨hal-02178306⟩
Collections
42
View
0
Download